ArticleThrombosis and haemostasis2020
Neutrophil-Platelet and Monocyte-Platelet Aggregates in COVID-19 Patients.
Abstract readLetterComment
In one paragraph
Article in Thrombosis and haemostasis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.
0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed.
- Immunomodulation by intravenous omega-3 fatty acid treatment in older subjects hospitalized for COVID-19: A single-blind randomized controlled trial.Clinical and translational medicine · 2022Trial
- Automatic classification of circulating blood cell clusters based on multi-channel flow cytometry imaging.Engineering applications of artificial intelligence · 2026Article
- Automatic Classification of Circulating Blood Cell Clusters based on Multi-channel Flow Cytometry Imaging.bioRxiv : the preprint server for biology · 2025Article
- Review
- Structural and functional changes underlying activation of monocytes in heparin-induced thrombocytopenia.Journal of thrombosis and haemostasis : JTH · 2025Article
- Platelet-Leukocyte Aggregate and Interleukin-6: An Emerging Perspective on a New Diagnostic and Therapeutic Clue for Acute Coronary Syndrome, A Case-Control Study.Health science reports · 2024Article
- The differential formation and composition of leukocyte-platelet aggregates induced by various cellular stimulants.Thrombosis research · 2024Article
- Association of elevated circulating monocyte-platelet aggregates with hypercoagulability in patients with nephrotic syndrome.Thrombosis journal · 2024Article
- Clinical significance of platelet mononuclear cell aggregates in patients with sepsis and acute respiratory distress syndrome.World journal of clinical cases · 2024Article
- Does SARS-CoV-2 infect platelets?Frontiers in immunology · 2024Article
- Expression of Tissue Factor and Platelet/Leukocyte Markers on Extracellular Vesicles Reflect Platelet-Leukocyte Interaction in Severe COVID-19.International journal of molecular sciences · 2023Article
- Changes in the Proteome of Platelets from Patients with Critical Progression of COVID-19.Cells · 2023Article
- Cargo-free particles divert neutrophil-platelet aggregates to reduce thromboinflammation.Nature communications · 2023Article
- P2Y12 Inhibition Suppresses Proinflammatory Platelet-Monocyte Interactions.Thrombosis and haemostasis · 2023Article
- Coagulation Disorders in Sepsis and COVID-19-Two Sides of the Same Coin? A Review of Inflammation-Coagulation Crosstalk in Bacterial Sepsis and COVID-19.Journal of clinical medicine · 2023Review
- Platelet-Neutrophil Crosstalk in Thrombosis.International journal of molecular sciences · 2023Review
- Duplicated Inferior Vena Cava Thrombosis Mimicking Acute Pancreatitis in a COVID-19 Patient.Cureus · 2023Article
- Platelet-monocyte aggregates: molecular mediators of thromboinflammation.Frontiers in cardiovascular medicine · 2023Review
- Platelet-neutrophil interaction in COVID-19 and vaccine-induced thrombotic thrombocytopenia.Frontiers in immunology · 2023Review
- Early SARS-CoV-2 infection: Platelet-neutrophil complexes and platelet function.Research and practice in thrombosis and haemostasis · 2023Article
Corrections and comments
- Comment on
Authors and funding
17 authors.
Alexandre Le JoncourDepartment of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Sorbonne Universités, Paris, France.ORCID 0000-0001-7583-0445
Lucie BiardDepartment of Biostatistics and Medical Information, CRESS UMR 1153, INSERM, ECSTRRA Team, Saint-Louis University Hospital, AP-HP, University of Paris, Paris, France.
Mathieu VautierDepartment of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Sorbonne Universités, Paris, France.
Helene BugautDepartment of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Sorbonne Universités, Paris, France.
Arsene MekinianService de Médecine Interne and Inflammation-Immunopathology-Biotherapy Department (DMU i3), Hôpital Saint-Antoine, APHP, Sorbonne Université, Paris, France.
Georgina MaaloufDepartment of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Sorbonne Universités, Paris, France.
Matheus VieiraDepartment of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Sorbonne Universités, Paris, France.
Anne-Geneviève MarcelinDepartment of Virology, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Groupe Hospitalier Pitié Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.
Michelle RosenzwajgSorbonne Université-INSERM UMRS959, Immunology-Immunopathology-Immunotherapy (I3), Biotherapy (CIC-BTi), Pitié- Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.
David KlatzmannSorbonne Université-INSERM UMRS959, Immunology-Immunopathology-Immunotherapy (I3), Biotherapy (CIC-BTi), Pitié- Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.
Jean-Christophe CorvolDepartment of Neurology, Clinical Investigation Center for Neurosciences, Inserm, CNRS, Paris Brain Institute - ICM, Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, Sorbonne Université, Paris, France.
Olivier PaccoudDepartment of Infectious and tropical disease, Groupe Hospitalier Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France.
Aude CarillionDepartment of Anesthesiology and Critical Care Medicine, Institut de Cardiologie, UMR INSERM 1166, IHU ICAN, Groupe Hospitalier Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France.
Joe-Elie SalemCIC (CIC-1901), CLIP2 Galilée, Department of Pharmacology and Clinical Investigation Center, Groupe Hospitalier Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France.
Patrice CacoubDepartment of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Sorbonne Universités, Paris, France.
Yacine BoulaftaliINSERM UMRS 1148 -LVTS, Laboratory for Vascular Translational Science Université de Paris GH Bichat-Claude Bernard, Paris, France.
David SaadounDepartment of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Sorbonne Universités, Paris, France.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19Respiratory Distress SyndromeBlood PlateletsHumansLipMonocytesNeutrophilsSARS-CoV-2
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.